Supplemental material
Journal of Medical Economics
Volume 23, 2020 - Issue 6
Open access
4,240
Views
6
CrossRef citations to date
0
Altmetric
Oncology
A cost analysis of SIR-Spheres yttrium-90 resin microspheres versus tyrosine kinase inhibitors in the treatment of unresectable hepatocellular carcinoma in France, Italy, Spain and the UK
Richard F. PollockHealth Economics and Outcomes Research, Covalence Research Ltd, London, UK; Correspondence[email protected]
http://orcid.org/0000-0002-9873-7507
Fabien ColaoneReimbursement and Market Access, Sirtex Medical United Kingdom Ltd, London, UK
, Laura GuardiolaReimbursement and Market Access, Sirtex Medical United Kingdom Ltd, London, UK
, Suki ShergillReimbursement and Market Access, Sirtex Medical United Kingdom Ltd, London, UK
& Victoria K. BrennanReimbursement and Market Access, Sirtex Medical United Kingdom Ltd, London, UK
Pages 593-602
|
Received 13 Nov 2019, Accepted 11 Feb 2020, Published online: 01 May 2020
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.